查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1659439

全球粒子治療市場

Particle Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 83 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球粒子治療市場規模將達到 28 億美元

2024 年全球粒子束治療市場規模估計為 17 億美元，預計到 2030 年將達到 28 億美元，2024 年至 2030 年的複合年成長率為 8.8%。質子治療是報告中分析的一個領域，預計到分析期結束時複合年成長率為 9.2%，達到 23 億美元。在分析期內，重離子治療領域預計將以 7.1% 的複合年成長率成長。

美國市場規模估計為 4.814 億美元，中國市場預計複合年成長率為 8.0%

預計2024年美國粒子治療市值將達4.814億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 4.321 億美元，在 2024 年至 2030 年的分析期內，複合年成長率為 8.0%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 8.3% 和 7.0%。在歐洲，預計德國的複合年成長率約為 7.0%。

全球粒子治療市場-主要趨勢與促進因素摘要

為什麼粒子束療法對於現代癌症治療至關重要？

粒子治療提供精確、有針對性的放射治療，同時最大限度地減少對周圍健康組織的損害，使其成為現代癌症治療中必不可少且高效的治療選擇。與傳統的基於光子的輻射不同，粒子療法使用帶電粒子，例如質子或碳離子，使腫瘤學家能夠將高劑量的輻射直接傳送到腫瘤，同時保護相鄰的健康組織。這種精確度在治療靠近重要結構的癌症時尤其有價值，例如腦腫瘤、兒童癌症或脊髓附近的腫瘤，因為保留健康組織至關重要。因此，粒子治療已成為治療複雜難治癌症的基石，顯著改善了治療效果並減少了副作用。

除了精確度之外，粒子療法還能在腫瘤部位提供高劑量強度，這使其對不太可能對常規放射治療產生反應的放射抗性腫瘤特別有效。粒子束的獨特性質，例如布拉格峰效應，可將最大能量直接傳送到腫瘤部位，從而減少腫瘤外的輻射暴露。這一優勢有助於最大限度地減少副作用和長期併發症，這對於兒科患者和癌症位於敏感器官附近的患者尤其有益。對於患者來說，粒子治療意味著更少的併發症和更短的治療時間，使其成為現代腫瘤學精準癌症治療的首選。

此外，粒子治療可以根據每個患者腫瘤的特徵制定治療計劃，從而適應個人化癌症治療的趨勢。影像和治療計劃的進步使得腫瘤學家能夠使用粒子療法根據腫瘤的大小、形狀和位置以無與倫比的精度瞄準腫瘤，提供改善治療效果的個人化治療方法。這種能力使粒子治療成為精準腫瘤學的重要組成部分，有助於滿足高度標靶治療需求，改善患者治療效果，同時減輕癌症治療帶來的身體和心理負擔。

科技進步如何增強粒子療法？

技術進步顯著提高了粒子治療的有效性、可近性和效率，擴大了其在癌症治療中的應用和吸引力。該領域最重要的創新之一是調變質子治療 (IMPT) 的發展，它可以實現更高的劑量分佈精度。 IMPT 允許腫瘤學家調整質子束的強度，使他們能夠更精確地將其塑造成腫瘤的輪廓並更有效地保護附近的健康組織。這種高度的控制降低了放射引起的副作用的風險，對於複雜和形狀不規則的腫瘤尤其有益。隨著 IMPT 技術的不斷進步，它正在改善具有挑戰性的癌症類型的患者的治療效果並提高粒子治療的整體效果。

即時MRI和PET掃描等先進影像技術的整合，透過提供詳細的即時影像來指南治療，進一步提高了粒子治療的精準度。這些影像技術使腫瘤學家能夠精確定位腫瘤的位置，並根據腫瘤的運動（例如呼吸或患者的運動）調整治療參數。將即時成像與粒子療法結合，可以幫助腫瘤學家提供更精確、更適應的治療，確保輻射到達腫瘤，同時保護周圍組織。這項創新支持自適應粒子治療，允許隨著腫瘤對治療的反應變化而動態調整治療，從而提高療效並最大限度地減少副作用。

單室質子治療設備等緊湊、經濟高效的粒子治療系統的發展提高了粒子治療的可及性和可負擔性。傳統上，粒子束治療需要大型、複雜且昂貴的設施，而且全球只有少數人能夠使用這些設施。然而，小型化系統的進步使得更多的醫院和癌症中心能夠採用粒子治療技術，使更多的患者能夠使用這種技術。這些緊湊的系統減少了對廣泛基礎設施的需求，大大降低了成本，並使當地醫院和區域癌症中心能夠提供這種先進的治療。透過使粒子療法更加經濟實惠且更廣泛地應用，這些技術進步將擴大其覆蓋範圍並為更多患者帶來精準的癌症治療。

粒子治療對病人和醫療保健系統有哪些益處？

粒子療法為癌症治療提供了一種精確、有效且對患者友好的方法，為患者和醫療保健系統帶來了顯著的益處。對於患者來說，粒子療法的主要優點之一是它最大限度地減少了對健康組織的損害並減少了短期和長期的副作用。這種組織保護特性對於兒科患者和腫瘤位於精細結構附近的患者尤其有價值，因為它可以降低併發症的風險並維持生活品質。粒子束治療可最大限度地減少周圍組織的放射線暴露，使治療的副作用更少，從而加快恢復速度並改善治療後的生活品質。這種益處對於年輕患者尤其有益，因為它可以降低與輻射暴露相關的繼發性癌症和發育問題的風險。

對於醫療保健系統來說，粒子療法降低了與管理放射相關副作用和併發症相關的長期照護成本。傳統放射治療通常需要大量的治療後護理來控制放射性皮膚炎、器官損傷甚至繼發性惡性腫瘤等副作用。粒子治療的精確定位顯著降低了這些併發症的發生率，從而減少了住院時間並減少了後續治療的需要。治療後併發症的減少意味著醫療保健系統的成本節省，並允許更有效地分配資源。透過支持更好的患者治療結果和更少的長期影響，粒子療法有助於更永續治療癌症，並為醫療保健系統帶來財務和營運效益。

粒子療法也符合個人化、精準腫瘤治療的轉變，使醫療保健提供者能夠根據每位患者腫瘤的特徵制定治療方案。先進的影像和治療計劃技術使腫瘤學家能夠根據腫瘤的位置、大小和形狀制定個人化的粒子治療通訊協定。這種個人化治療可以讓患者接受所需的確切輻射量，而不會受到不必要的暴露，從而提高治療效果並最佳化資源利用。對於醫療保健系統而言，個人化護理的能力將提高患者的滿意度和治療效果，從而提高粒子療法作為綜合癌症治療計劃的一部分的價值。粒子束治療對患者和醫療保健提供者的變革潛力是巨大的：改善生活品質，降低長期成本並支持精準癌症治療。

推動粒子治療市場成長的因素是什麼？

粒子束治療市場的成長受到癌症發病率上升、對微創和精準癌症治療的需求增加、粒子束治療技術的進步以及質子和碳離子治療中心的擴大等因素的推動。隨著全球癌症發生率持續上升，迫切需要先進的治療方案來改善治療效果並最大限度地減少副作用。粒子療法透過精確瞄準和減少對健康組織的影響，為傳統放射療法提供了一種有效且對患者友好的治療方法，從而滿足了這一需求。這種需求在兒科腫瘤學中尤其強烈，因為該領域最需要保留組織的治療。隨著全球癌症發病率的不斷上升，對粒子束治療等高精度治療的需求預計將推動市場擴張。

對微創癌症治療的需求不斷成長，進一步推動了粒子束治療市場的成長。患者和醫療保健提供者都在尋求能夠產生有效結果、副作用更少、恢復時間更短的治療方法。粒子治療透過將高劑量的輻射直接傳送到腫瘤同時保留周圍組織來滿足精確度和微創性的要求。粒子療法相對於傳統放射療法的優勢越來越被患者和醫療保健專業人士所認可，從而導致採用率不斷提高。隨著患者尋求平衡療效和生活品質的治療方法，粒子束治療正在成為治療複雜、高風險癌症的合適選擇。

此外，粒子治療技術的進步，例如粒子治療裝置的小型化和單室系統，也使得粒子治療更加方便且經濟實惠，從而進一步推動市場成長。這些緊湊的系統減少了傳統粒子治療設施所需的基礎設施和成本，使更多醫院和癌症中心能夠採用這種先進技術。此外，強度調變質子治療和自適應治療計劃等創新使粒子治療更加精確、適應性更強，從而能夠更有效地治療更多種癌症類型。隨著技術的不斷進步，粒子療法將在更廣泛的醫療機構中得到應用，擴大患者治療機會並推動市場成長。

粒子束治療中心的擴張，特別是在北美、歐洲和亞太等地區，也是推動市場成長的主要因素。世界各國政府和醫療保健組織都在投資粒子治療基礎設施，認知到其在癌症治療方面的好處以及降低長期醫療成本的潛力。此外，許多國家也提供報銷和財政援助，以使患者更容易接受粒子治療。隨著全球範圍內越來越多的粒子治療中心的建立，這種治療方法的可用性和認知度正在提高，從而推動了進一步的需求。這些因素的結合——癌症發病率的上升、精準治療的需求、技術進步和基礎設施的不斷擴大——導致了粒子治療市場的強勁成長，使其成為現代腫瘤學和個人化癌症治療的關鍵組成部分。

部分

種類（質子治療、重粒子治療）；系統（多室系統、單室系統）；用途（治療、研究）

受訪公司範例（22家值得關注的公司）

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips NV
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP22463

Global Particle Therapy Market to Reach US$2.8 Billion by 2030

The global market for Particle Therapy estimated at US$1.7 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Proton Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Heavy Ion Therapy segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$481.4 Million While China is Forecast to Grow at 8.0% CAGR

The Particle Therapy market in the U.S. is estimated at US$481.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$432.1 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.3% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Particle Therapy Market - Key Trends & Drivers Summarized

Why Is Particle Therapy Essential in Modern Cancer Treatment?

Particle therapy has become an essential and highly effective treatment option in modern cancer care, providing precise, targeted radiation therapy with minimal damage to surrounding healthy tissue. Unlike traditional photon-based radiation, particle therapy uses charged particles like protons and carbon ions, which allow oncologists to deliver a high dose of radiation directly to tumors while sparing adjacent healthy tissues. This precision is particularly valuable in treating cancers located near critical structures, such as brain tumors, pediatric cancers, and tumors near the spinal cord, where preserving healthy tissue is crucial. As a result, particle therapy has become a cornerstone in the treatment of complex and hard-to-treat cancers, significantly improving outcomes and reducing side effects.

In addition to its accuracy, particle therapy offers a higher dose intensity at the tumor site, making it particularly effective for radioresistant tumors, which are less responsive to traditional forms of radiation. The unique properties of particle beams, such as the Bragg peak effect, allow them to release maximum energy directly at the tumor site, reducing radiation exposure beyond the tumor. This advantage minimizes side effects and long-term complications, which is especially beneficial for pediatric patients and those with cancers near sensitive organs. For patients, particle therapy means a potentially shorter treatment course with fewer complications, making it a preferred option in modern oncology for high-precision cancer care.

Moreover, particle therapy aligns with the growing trend of personalized cancer treatment, as it allows for treatment plans that are tailored to the unique characteristics of each patient’s tumor. With advancements in imaging and treatment planning, oncologists can use particle therapy to target tumors with unparalleled precision based on size, shape, and location, providing an individualized approach that improves treatment efficacy. This capability makes particle therapy an essential part of precision oncology, addressing the need for highly targeted treatments that enhance patient outcomes while reducing the physical and emotional burden of cancer treatment.

How Are Technological Advancements Enhancing Particle Therapy?

Technological advancements are significantly enhancing the effectiveness, accessibility, and efficiency of particle therapy, broadening its application and appeal in cancer treatment. One of the most significant innovations in this field is the development of intensity-modulated proton therapy (IMPT), which allows for even greater precision in dose distribution. IMPT enables oncologists to modulate the intensity of the proton beam, shaping it more accurately to match the tumor’s contours and sparing nearby healthy tissues even more effectively. This enhanced control reduces the risk of radiation-induced side effects and is particularly beneficial for complex, irregularly shaped tumors. As IMPT technology continues to advance, it offers improved outcomes for patients with challenging cancer types, increasing the overall effectiveness of particle therapy.

The integration of advanced imaging technologies, such as real-time MRI and PET scans, has further improved the accuracy of particle therapy by providing detailed, real-time images that guide treatment. These imaging technologies enable oncologists to precisely locate tumors and adjust treatment parameters to account for tumor movement, such as breathing or patient shifts, which is particularly important for tumors in the lungs or abdomen. By combining real-time imaging with particle therapy, oncologists can deliver more accurate and adaptive treatments, ensuring that radiation is consistently targeted to the tumor while sparing surrounding tissues. This innovation supports adaptive particle therapy, allowing treatment to be dynamically adjusted as the tumor changes in response to therapy, enhancing effectiveness and minimizing side effects.

The development of compact and cost-effective particle therapy systems, such as single-room proton therapy units, has increased the accessibility and affordability of particle therapy. Traditionally, particle therapy required large, complex, and expensive facilities, limiting its availability to a select number of centers worldwide. However, advancements in compact systems have made it possible for more hospitals and cancer centers to adopt particle therapy technology, making it accessible to a broader patient population. These compact systems reduce the need for large-scale infrastructure, significantly lowering costs and enabling community hospitals and regional cancer centers to offer this advanced treatment. By making particle therapy more affordable and widely available, these technological advancements are expanding its reach, providing more patients with access to high-precision cancer care.

What Are the Benefits of Particle Therapy for Patients and Healthcare Systems?

Particle therapy offers substantial benefits for both patients and healthcare systems, providing a precise, effective, and patient-friendly approach to cancer treatment. For patients, one of the primary advantages of particle therapy is its ability to minimize damage to healthy tissues, reducing both short-term and long-term side effects. This tissue-sparing property is particularly valuable for pediatric patients and those with tumors near sensitive structures, as it reduces the risk of complications and preserves quality of life. By minimizing radiation exposure to surrounding tissues, particle therapy allows patients to undergo treatment with fewer side effects, leading to a quicker recovery and enabling a better post-treatment quality of life. This advantage is especially beneficial for young patients, as it lowers the risk of secondary cancers and developmental issues associated with radiation exposure.

For healthcare systems, particle therapy reduces the long-term care costs associated with managing radiation-induced side effects and complications. Traditional radiation treatments often require extensive post-treatment care to manage side effects such as radiation dermatitis, damage to organs, and even secondary malignancies. With particle therapy’s precise targeting, the incidence of such complications is significantly reduced, leading to fewer hospital admissions and a lower demand for follow-up treatments. This reduction in post-treatment complications translates into cost savings for healthcare systems and allows resources to be allocated more effectively. By supporting better patient outcomes with fewer long-term effects, particle therapy contributes to a more sustainable approach to cancer care, which benefits healthcare systems financially and operationally.

Particle therapy also aligns well with the shift toward personalized and precision oncology, enabling healthcare providers to deliver treatments that are tailored to the unique characteristics of each patient’s tumor. With advanced imaging and treatment planning technologies, oncologists can develop individualized particle therapy protocols based on tumor location, size, and shape. This personalization enhances treatment efficacy and optimizes resource use, as patients receive precisely the amount of radiation needed without unnecessary exposure. For healthcare systems, the ability to provide tailored treatment improves patient satisfaction and outcomes, reinforcing the value of particle therapy as part of a comprehensive cancer care program. Together, these benefits—improved quality of life, reduced long-term costs, and support for precision oncology—highlight the transformative potential of particle therapy for patients and healthcare providers alike.

What Is Fueling the Growth in the Particle Therapy Market?

The growth in the particle therapy market is driven by factors such as the rising incidence of cancer, increasing demand for minimally invasive and precise cancer treatments, advancements in particle therapy technology, and expanded access to proton and carbon ion therapy centers. As cancer incidence continues to rise globally, there is an urgent demand for advanced treatment options that improve outcomes while minimizing side effects. Particle therapy, with its precise targeting and reduced impact on healthy tissues, meets this demand by providing an effective, patient-friendly alternative to traditional radiation. This demand is particularly strong in pediatric oncology, where the need for tissue-sparing therapies is paramount. As the global cancer burden grows, the demand for high-precision treatments like particle therapy is expected to drive market expansion.

The increasing demand for minimally invasive cancer treatments has further fueled growth in the particle therapy market. Patients and healthcare providers alike are seeking treatments that provide effective results with fewer side effects and shorter recovery times. Particle therapy, with its ability to deliver high-dose radiation directly to tumors while sparing surrounding tissues, aligns with this demand for precision and minimal invasiveness. The market is benefiting from a growing awareness among patients and providers about the advantages of particle therapy over traditional radiation, leading to higher adoption rates. As patients increasingly seek treatments that balance efficacy with quality of life, particle therapy is emerging as a preferred option for complex and high-risk cancers.

Advancements in particle therapy technology, such as compact and single-room systems, are also driving market growth by making particle therapy more accessible and affordable. These compact systems reduce the infrastructure and cost requirements of traditional particle therapy facilities, enabling more hospitals and cancer centers to adopt this advanced technology. Additionally, innovations like intensity-modulated proton therapy and adaptive treatment planning have enhanced the precision and adaptability of particle therapy, increasing its effectiveness across a broader range of cancer types. As technology continues to improve, particle therapy is becoming more viable for a wider range of healthcare facilities, expanding patient access and fueling market growth.

The expansion of particle therapy centers, particularly in regions like North America, Europe, and Asia-Pacific, is another significant factor in market growth. Governments and healthcare organizations are investing in particle therapy infrastructure, recognizing its benefits for cancer care and the potential for long-term healthcare cost savings. Many countries are also offering reimbursement and funding support to make particle therapy more accessible to patients. As more particle therapy centers are established globally, the availability and awareness of this treatment are increasing, driving further demand. Together, these factors—rising cancer incidence, demand for precise treatments, technological advancements, and infrastructure expansion—are driving robust growth in the particle therapy market, positioning it as a crucial component of modern oncology and personalized cancer care.

SCOPE OF STUDY:

The report analyzes the Particle Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Proton Therapy, Heavy Ion Therapy); System (Multi-Room Systems, Single-Room Systems); Application (Treatment, Research)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 22 Featured) -

  • Accuray Incorporated
  • Advanced Oncotherapy
  • Brainlab
  • Danfysik A/S
  • Elekta AB
  • Hitachi Ltd.
  • IBA Worldwide
  • Koninklijke Philips N.V.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • Panacea
  • ProTom International
  • Provision Healthcare
  • PTW Freiburg GmbH
  • SAH Global LLC
  • Shinva Medical Instrument Co. Ltd
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems Inc.
  • xstrahl

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Particle Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Cancer Drives Demand for Particle Therapy Solutions
    • Advancements in Proton Therapy Technologies Propel Particle Therapy Market
    • Increasing Adoption of Carbon Ion Therapy Expands Addressable Market
    • Growing Focus on Minimally Invasive Cancer Treatments Sets the Stage for Market Expansion
    • Innovations in Beam Delivery Systems Propel Particle Therapy Adoption
    • Demand for Pediatric Cancer Treatments Expands Particle Therapy Applications
    • Growing Awareness About Particle Therapy in Developing Economies Bodes Well for Market Growth
    • Increasing Use in Recurrent Tumor Treatments Sets the Stage for Market Growth
    • Demand for Proton Beam Therapy in Brain and Lung Cancers Spurs Adoption
    • Increasing Use in Proton Therapy for Prostate Cancer Sets the Stage for Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Particle Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Heavy Ion Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Heavy Ion Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Multi-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Multi-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Single-Room Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Single-Room Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Particle Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • JAPAN
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • CHINA
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • EUROPE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Particle Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Particle Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • FRANCE
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • GERMANY
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Europe 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Particle Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Particle Therapy by Type - Proton Therapy and Heavy Ion Therapy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of World 15-Year Perspective for Particle Therapy by Type - Percentage Breakdown of Value Sales for Proton Therapy and Heavy Ion Therapy for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by System - Multi-Room Systems and Single-Room Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World Historic Review for Particle Therapy by System - Multi-Room Systems and Single-Room Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of World 15-Year Perspective for Particle Therapy by System - Percentage Breakdown of Value Sales for Multi-Room Systems and Single-Room Systems for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of World Recent Past, Current & Future Analysis for Particle Therapy by Application - Treatment and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of World Historic Review for Particle Therapy by Application - Treatment and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of World 15-Year Perspective for Particle Therapy by Application - Percentage Breakdown of Value Sales for Treatment and Research for the Years 2015, 2025 & 2030

IV. COMPETITION